Literature DB >> 31905235

High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada.

Ilan S Schwartz1, Daniel Z P Friedman1, Lori Zapernick1, Tanis C Dingle2, Nelson Lee1, Wendy Sligl1,3, Nathan Zelyas2, Stephanie W Smith1.   

Abstract

From 2014-2019, invasive pulmonary aspergillosis complicated 7.2% (0-23.1% in different influenza seasons) of cases of influenza-associated respiratory failure in Edmonton, Alberta. Disease outcomes ranged from survival without therapy to death despite antifungals. Clinician vigilance, longitudinal local surveillance, and refined criteria to identify patients requiring therapy are needed.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Aspergilluszzm321990 ; aspergillosis; emerging infections; influenza; intensive care

Year:  2020        PMID： 31905235     DOI： 10.1093/cid/ciaa007

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  29 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

2.  Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019.

Authors:  Jeremy A W Gold; Andrew Revis; Stepy Thomas; Lewis Perry; Rebekah A Blakney; Taylor Chambers; Meghan L Bentz; Elizabeth L Berkow; Shawn R Lockhart; Colleen Lysen; Natalie S Nunnally; Alexander Jordan; Hilary C Kelly; Alejandro J Montero; Monica M Farley; Nora T Oliver; Stephanie M Pouch; Andrew S Webster; Brendan R Jackson; Karlyn D Beer
Journal:  Open Forum Infect Dis       Date:  2022-04-21       Impact factor: 4.423

Review 3.  Mechanistic Basis of Super-Infection: Influenza-Associated Invasive Pulmonary Aspergillosis.

Authors:  Keven Mara Robinson
Journal:  J Fungi (Basel)       Date:  2022-04-22

4.  How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?

Authors:  Pablo González-García; Montserrat Alonso-Sardón; Beatriz Rodríguez-Alonso; Hugo Almeida; Ángela Romero-Alegría; Víctor-José Vega-Rodríguez; Amparo López-Bernús; Juan Luis Muñoz-Bellido; Antonio Muro; Javier Pardo-Lledías; Moncef Belhassen-García
Journal:  J Fungi (Basel)       Date:  2022-05-27

5.  Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

Authors:  Paul E Verweij; Bart J A Rijnders; Roger J M Brüggemann; Elie Azoulay; Matteo Bassetti; Stijn Blot; Thierry Calandra; Cornelius J Clancy; Oliver A Cornely; Tom Chiller; Pieter Depuydt; Daniele Roberto Giacobbe; Nico A F Janssen; Bart-Jan Kullberg; Katrien Lagrou; Cornelia Lass-Flörl; Russell E Lewis; Peter Wei-Lun Liu; Olivier Lortholary; Johan Maertens; Ignacio Martin-Loeches; M Hong Nguyen; Thomas F Patterson; Thomas R Rogers; Jeroen A Schouten; Isabel Spriet; Lore Vanderbeke; Joost Wauters; Frank L van de Veerdonk
Journal:  Intensive Care Med       Date:  2020-06-22       Impact factor: 17.440

6.  Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.

Authors:  Marion Blaize; Julien Mayaux; Cécile Nabet; Alexandre Lampros; Anne-Geneviève Marcelin; Marc Thellier; Renaud Piarroux; Alexandre Demoule; Arnaud Fekkar
Journal:  Emerg Infect Dis       Date:  2020-06-21       Impact factor: 6.883

7.  Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.

Authors:  Lore Vanderbeke; Nico A F Janssen; Roger J M Brüggemann; Joost Wauters; Dennis C J J Bergmans; Marc Bourgeois; Jochem B Buil; Yves Debaveye; Pieter Depuydt; Simon Feys; Greet Hermans; Oscar Hoiting; Ben van der Hoven; Cato Jacobs; Katrien Lagrou; Virginie Lemiale; Piet Lormans; Johan Maertens; Philippe Meersseman; Bruno Mégarbane; Saad Nseir; Jos A H van Oers; Marijke Reynders; Bart J A Rijnders; Jeroen A Schouten; Isabel Spriet; Karin Thevissen; Arnaud W Thille; Ruth Van Daele; Frank L van de Veerdonk; Paul E Verweij; Alexander Wilmer
Journal:  Intensive Care Med       Date:  2021-05-29       Impact factor: 17.440

Review 8.  Invasive mould disease in fatal COVID-19: a systematic review of autopsies.

Authors:  Brittany E Kula; Cornelius J Clancy; M Hong Nguyen; Ilan S Schwartz
Journal:  Lancet Microbe       Date:  2021-06-23

9.  Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19.

Authors:  George R Thompson Iii; Oliver A Cornely; Peter G Pappas; Thomas F Patterson; Martin Hoenigl; Jeffrey D Jenks; Cornelius J Clancy; M Hong Nguyen
Journal:  Open Forum Infect Dis       Date:  2020-06-19       Impact factor: 3.835

10.  Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report.

Authors:  Juergen Prattes; Thomas Valentin; Martin Hoenigl; Emina Talakic; Alexander C Reisinger; Philipp Eller
Journal:  Med Mycol Case Rep       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.